vs

Side-by-side financial comparison of FONAR CORP (FONR) and HARTE HANKS INC (HHS). Click either name above to swap in a different company.

HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $25.5M, roughly 1.6× FONAR CORP). FONAR CORP runs the higher net margin — 8.0% vs 5.5%, a 2.5% gap on every dollar of revenue. On growth, FONAR CORP posted the faster year-over-year revenue change (2.4% vs -15.4%). FONAR CORP produced more free cash flow last quarter ($-227.0K vs $-686.0K). Over the past eight quarters, FONAR CORP's revenue compounded faster (-0.3% CAGR vs -6.4%).

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

FONR vs HHS — Head-to-Head

Bigger by revenue
HHS
HHS
1.6× larger
HHS
$39.9M
$25.5M
FONR
Growing faster (revenue YoY)
FONR
FONR
+17.8% gap
FONR
2.4%
-15.4%
HHS
Higher net margin
FONR
FONR
2.5% more per $
FONR
8.0%
5.5%
HHS
More free cash flow
FONR
FONR
$459.0K more FCF
FONR
$-227.0K
$-686.0K
HHS
Faster 2-yr revenue CAGR
FONR
FONR
Annualised
FONR
-0.3%
-6.4%
HHS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FONR
FONR
HHS
HHS
Revenue
$25.5M
$39.9M
Net Profit
$2.1M
$2.2M
Gross Margin
Operating Margin
13.5%
-0.3%
Net Margin
8.0%
5.5%
Revenue YoY
2.4%
-15.4%
Net Profit YoY
4.7%
EPS (diluted)
$0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FONR
FONR
HHS
HHS
Q4 25
$25.5M
$39.9M
Q3 25
$26.0M
$39.5M
Q2 25
$27.3M
$38.6M
Q1 25
$27.2M
$41.6M
Q4 24
$24.9M
$47.1M
Q3 24
$25.0M
$47.6M
Q2 24
$25.9M
$45.0M
Q1 24
$25.7M
$45.4M
Net Profit
FONR
FONR
HHS
HHS
Q4 25
$2.1M
$2.2M
Q3 25
$2.3M
$-2.3M
Q2 25
$729.3K
$-335.0K
Q1 25
$2.5M
$-392.0K
Q4 24
$2.0M
Q3 24
$3.1M
$142.0K
Q2 24
$830.4K
$-27.8M
Q1 24
$1.9M
$-171.0K
Operating Margin
FONR
FONR
HHS
HHS
Q4 25
13.5%
-0.3%
Q3 25
14.1%
1.3%
Q2 25
5.3%
0.1%
Q1 25
15.2%
-0.1%
Q4 24
11.9%
-3.3%
Q3 24
21.0%
4.0%
Q2 24
7.4%
3.0%
Q1 24
16.8%
0.8%
Net Margin
FONR
FONR
HHS
HHS
Q4 25
8.0%
5.5%
Q3 25
8.7%
-5.8%
Q2 25
2.7%
-0.9%
Q1 25
9.2%
-0.9%
Q4 24
7.9%
Q3 24
12.6%
0.3%
Q2 24
3.2%
-61.8%
Q1 24
7.3%
-0.4%
EPS (diluted)
FONR
FONR
HHS
HHS
Q4 25
$0.30
Q3 25
$-0.31
Q2 25
$-0.05
Q1 25
$-0.05
Q4 24
$-0.31
Q3 24
$0.02
Q2 24
$-3.84
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FONR
FONR
HHS
HHS
Cash + ST InvestmentsLiquidity on hand
$121.0K
$5.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$176.9M
$20.5M
Total Assets
$217.2M
$91.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FONR
FONR
HHS
HHS
Q4 25
$121.0K
$5.6M
Q3 25
$122.0K
$6.5M
Q2 25
$56.5M
$4.8M
Q1 25
$123.0K
$9.0M
Q4 24
$121.0K
$9.8M
Q3 24
$136.0K
$5.9M
Q2 24
$56.5M
$11.0M
Q1 24
$134.0K
$11.5M
Total Debt
FONR
FONR
HHS
HHS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$66.9K
Q1 24
Stockholders' Equity
FONR
FONR
HHS
HHS
Q4 25
$176.9M
$20.5M
Q3 25
$174.9M
$19.9M
Q2 25
$172.6M
$22.2M
Q1 25
$171.9M
$21.4M
Q4 24
$169.8M
$21.7M
Q3 24
$168.7M
$21.0M
Q2 24
$166.0M
$20.6M
Q1 24
$165.8M
$20.0M
Total Assets
FONR
FONR
HHS
HHS
Q4 25
$217.2M
$91.8M
Q3 25
$218.4M
$92.7M
Q2 25
$216.9M
$95.0M
Q1 25
$214.9M
$100.6M
Q4 24
$208.0M
$101.8M
Q3 24
$212.3M
$108.1M
Q2 24
$214.2M
$109.7M
Q1 24
$209.6M
$113.4M
Debt / Equity
FONR
FONR
HHS
HHS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FONR
FONR
HHS
HHS
Operating Cash FlowLast quarter
$171.0K
$737.0K
Free Cash FlowOCF − Capex
$-227.0K
$-686.0K
FCF MarginFCF / Revenue
-0.9%
-1.7%
Capex IntensityCapex / Revenue
1.6%
3.6%
Cash ConversionOCF / Net Profit
0.08×
0.33×
TTM Free Cash FlowTrailing 4 quarters
$5.7M
$-4.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FONR
FONR
HHS
HHS
Q4 25
$171.0K
$737.0K
Q3 25
$1.7M
$3.2M
Q2 25
$4.2M
$-4.8M
Q1 25
$3.1M
$-818.0K
Q4 24
$2.2M
$4.0M
Q3 24
$1.7M
$-2.9M
Q2 24
$4.6M
$1.6M
Q1 24
$2.8M
$-5.7M
Free Cash Flow
FONR
FONR
HHS
HHS
Q4 25
$-227.0K
$-686.0K
Q3 25
$-177.0K
$2.2M
Q2 25
$3.6M
$-5.1M
Q1 25
$2.6M
$-923.0K
Q4 24
$1.5M
$3.4M
Q3 24
$-148.0K
$-4.9M
Q2 24
$4.2M
$926.0K
Q1 24
$2.6M
$-6.2M
FCF Margin
FONR
FONR
HHS
HHS
Q4 25
-0.9%
-1.7%
Q3 25
-0.7%
5.5%
Q2 25
13.1%
-13.1%
Q1 25
9.4%
-2.2%
Q4 24
6.0%
7.3%
Q3 24
-0.6%
-10.2%
Q2 24
16.1%
2.1%
Q1 24
10.2%
-13.7%
Capex Intensity
FONR
FONR
HHS
HHS
Q4 25
1.6%
3.6%
Q3 25
7.2%
2.5%
Q2 25
2.4%
0.6%
Q1 25
2.2%
0.3%
Q4 24
3.0%
1.3%
Q3 24
7.2%
4.0%
Q2 24
1.6%
1.5%
Q1 24
0.7%
1.2%
Cash Conversion
FONR
FONR
HHS
HHS
Q4 25
0.08×
0.33×
Q3 25
0.75×
Q2 25
5.79×
Q1 25
1.26×
Q4 24
1.14×
Q3 24
0.53×
-20.76×
Q2 24
5.54×
Q1 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

Related Comparisons